Westlake, W.J. (1981) Response to T.B.L. Kirkwood: Bioequivalence Testing—A Need to Rethink. Biometrics, 37, 589-594.
https://doi.org/10.2307/2530573

has been cited by the following article:

• TITLE: TrueBeam Low Dose Rate Investigation for Pulsed Reduced Dose Rate IMRT

  AUTHORS: Mark Geurts

  KEYWORDS: PRDR, Low Dose Rate, Delta 4, TrueBeam

  JOURNAL NAME: International Journal of Medical Physics, Clinical Engineering and Radiation Oncology, Vol.6 No.2, May 22, 2017

  ABSTRACT: The capability of the TrueBeam treatment system to deliver step and shoot IMRT plans at low dose rates was evaluated. Beam characteristics during low dose rates (5 to 100 MU/min) were evaluated for consistency using a planar ion chamber array. MU constancy, linearity, and beam profile symmetry were all found to be equivalent within 0.5%. The response of the Scandi Dos Delta 4 system was also evaluated at low dose rates of using static open beams compared to ion chamber measurements, and step and shoot IMRT plans comparing 5 - 20 MU/min and 100 MU/min dose rates, with a maximum observed absolute dose difference of 0.8% and equivalence margin of 0.2%. The Gamma Index and measurement reproducibility were also found to be equivalent.